News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
235 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19011)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2884)
Day
1 (174)
2 (228)
3 (196)
4 (100)
8 (238)
9 (249)
10 (206)
11 (114)
14 (172)
15 (198)
16 (171)
17 (132)
18 (113)
21 (178)
22 (159)
23 (151)
24 (168)
25 (130)
28 (235)
29 (233)
30 (206)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
Drug Development
OncoGenex Presents Additional Phase 3 SYNERGY Analyses Showing Custirsen Significantly Reduced Serum Clusterin Levels In Metastatic Prostate Cancer Patients; Low Levels Correlate With Improved Survival In Those At Increased Risk For Poor Outcomes
September 28, 2015
·
9 min read
Drug Development
Synthetic Biologics, Inc. Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial
September 28, 2015
·
7 min read
Drug Development
OncoSec Medical Inc. Announces Positive Results From Phase II Trial Of ImmunoPulse IL-12 In Merkel Cell Carcinoma
September 28, 2015
·
7 min read
Drug Development
Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial Of VTS-270 For Treatment Of Niemann-Pick Type C1 (NPC) Disease
September 28, 2015
·
5 min read
Drug Development
IMPAX Labs Receives Positive CHMP Opinion for NUMIENT (Levodopa And Carbidopa) Modified-Release Capsules For The Symptomatic Treatment Of Adult Patients With Parkinson’s Disease
September 28, 2015
·
9 min read
Drug Development
Regen BioPharma Announces Positive Results From GLP Safety Study For HemaXellerate
September 28, 2015
·
2 min read
Biotech Bay
Genomic Health, Inc. Release: Two Large International Studies Provide Additional Prospective Data Reinforcing The Ability Of Oncotype DX To Accurately Predict Clinical Outcomes In Early-Stage Breast Cancer Patients
September 28, 2015
·
6 min read
Drug Development
Novartis AG Drug Afinitor Significantly Improves Progression-Free Survival In Advanced Nonfunctional Gastrointestinal And Lung NET
September 28, 2015
·
11 min read
AEterna Zentaris Announces TSX Approval Of Series B Warrant Amendment
September 28, 2015
·
2 min read
Biotech Bay
Thoratec Release: HeartMate 3 CE Mark Trial Meets Primary Endpoint
September 28, 2015
·
6 min read
1 of 24
Next
